A Study of Mirikizumab (LY3074828) in Healthy Participants
Status:
Completed
Trial end date:
2018-07-16
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to explore the safety and tolerability of mirikizumab in
healthy Japanese and Caucasian participants. The study will also estimate how much
mirikizumab gets into the blood stream and how long it takes the body to remove it. The study
is expected to last about 16 weeks for each participant.